A detailed history of Barclays PLC transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Barclays PLC holds 262,449 shares of MDXG stock, worth $2.49 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
262,449
Previous 262,449 -0.0%
Holding current value
$2.49 Million
Previous $1.55 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$5.65 - $7.76 $920,978 - $1.26 Million
163,005 Added 163.92%
262,449 $1.55 Million
Q2 2024

Aug 14, 2024

SELL
$6.16 - $8.08 $251,445 - $329,817
-40,819 Reduced 29.1%
99,444 $689,000
Q1 2024

May 15, 2024

SELL
$7.61 - $8.63 $1.03 Million - $1.17 Million
-135,455 Reduced 49.13%
140,263 $1.08 Million
Q4 2023

Feb 15, 2024

BUY
$5.7 - $9.14 $1.57 Million - $2.52 Million
275,644 Added 372491.88%
275,718 $2.42 Million
Q3 2023

Nov 07, 2023

BUY
$6.35 - $8.16 $469 - $603
74 New
74 $1,000
Q1 2023

May 04, 2023

BUY
$2.97 - $4.81 $653 - $1,058
220 New
220 $1,000
Q2 2022

Aug 12, 2022

BUY
$3.17 - $5.0 $2,418 - $3,815
763 New
763 $3,000
Q4 2021

Feb 14, 2022

SELL
$5.7 - $8.48 $57,000 - $84,800
-10,000 Closed
0 $0
Q3 2021

Nov 09, 2021

BUY
$5.52 - $15.83 $55,199 - $158,300
10,000 New
10,000 $61,000
Q4 2018

Feb 14, 2019

SELL
$1.15 - $6.45 $220,333 - $1.24 Million
-191,594 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$3.22 - $6.33 $249,250 - $489,986
77,407 Added 67.79%
191,594 $1.18 Million
Q2 2018

Aug 14, 2018

SELL
$5.39 - $8.96 $150,806 - $250,691
-27,979 Reduced 19.68%
114,187 $730,000
Q1 2018

May 15, 2018

BUY
$6.69 - $17.96 $650,421 - $1.75 Million
97,223 Added 216.33%
142,166 $991,000
Q4 2017

Feb 14, 2018

SELL
$10.87 - $13.9 $8.09 Million - $10.3 Million
-744,379 Reduced 94.31%
44,943 $566,000
Q3 2017

Nov 14, 2017

BUY
$11.86 - $17.34 $9.36 Million - $13.7 Million
789,322
789,322 $9.38 Million

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $1.08B
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.